Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1628-1639

  Wang, Zekun ^a   Mir, Mohammad A ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NUCLEOCAPSID PROTEIN; PROTEIN KINASE R;

ANDES VIRUS; ARTICLE; AUTOPHOSPHORYLATION; BUNYAVIRIDAE; CONTROLLED STUDY; CYTOKINE RESPONSE; DIMERIZATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SENSITIVITY ANALYSIS; VIRUS IDENTIFICATION; VIRUS INTERFERENCE; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS SURVIVAL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; HANTAVIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING;

ANDES VIRUS; EUKARYOTA; HANTAVIRUS;

ANIMALS; CELL LINE; EIF-2 KINASE; HANTAVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; NUCLEOCAPSID PROTEINS; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84921495449     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02347-14     Document Type: Article

References (68)

1. Khaiboullina SF, Morzunov SP, St Jeor SC. 2005. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 5:773-790. http://dx.doi.org/10.2174/156652405774962317.
2. Lober C, Anheier B, Lindow S, Klenk HD, Feldmann H. 2001. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 289:224-229. http://dx.doi.org/10.1006/viro.2001.1171.
3. Jonsson CB, Figueiredo LT, Vapalahti O. 2010. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 23:412-441. http://dx.doi.org/10.1128/CMR.00062-09.
4. Bi Z, Formenty PB, Roth CE. 2008. Hantavirus infection: a review and global update. J Infect Dev Ctries 2:3-23. http://dx.doi.org/10.3855/jidc.317.
5. Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241:323-330. http://dx.doi.org/10.1006/viro.1997.8976.
6. Cheng E, Mir MA. 2012. Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching. J Virol 86:10173-10185. http://dx.doi.org/10.1128/JVI.05560-11.
7. Mir MA, Duran WA, Hjelle BL, Ye C, Panganiban AT. 2008. Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc Natl Acad Sci U S A 105:19294-19299. http://dx.doi.org/10.1073/pnas.0807211105.
8. Hopkins KC, McLane LM, Maqbool T, Panda D, Gordesky-Gold B, Cherry S. 2013. A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching. Genes Dev 27:1511-1525. http://dx.doi.org/10.1101/gad.215384.113.
9. Mir MA, Panganiban AT. 2008. A protein that replaces the entire cellular eIF4F complex. EMBO J 27:3129-3139. http://dx.doi.org/10.1038/emboj.2008.228.
10. Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, Geimonen E, Sen N, Reich NC, Mackow ER. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80:9676-9686. http://dx.doi.org/10.1128/JVI.00508-06.
11. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 99:13837-13842. http://dx.doi.org/10.1073/pnas.192298899.
12. Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN, Mackow ER. 2008. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J Virol 82:9115-9122. http://dx.doi.org/10.1128/JVI.00290-08.
13. Stoltz M, Ahlm C, Lundkvist A, Klingstrom J. 2007. Lambda interferon (IFN-λ) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-γ-induced nitric oxide production. J Virol 81:8685-8691. http://dx.doi.org/10.1128/JVI.00415-07.
14. Samuel CE. 1979. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A 76:600-604. http://dx.doi.org/10.1073/pnas.76.2.600.
15. Goodbourn S, Didcock L, Randall RE. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341-2364.
16. Dauber B, Wolff T. 2009. Activation of the antiviral kinase PKR and viral countermeasures. Viruses 1:523-544. http://dx.doi.org/10.3390/v1030523.
17. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032-1060. http://dx.doi.org/10.1128/MMBR.00027-06.
18. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL. 2006. Inhibition of PKR byRNAandDNAviruses. Virus Res 119:100-110. http://dx.doi.org/10.1016/j.virusres.2005.10.014.
19. Kutner RH, Zhang XY, Reiser J. 2009. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4:495-505. http://dx.doi.org/10.1038/nprot.2009.22.
20. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6-14. http://dx.doi.org/10.1006/viro.2001.1133.
21. Mir MA, Sheema S, Haseeb A, Haque A. 2010. Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites. J Biol Chem 285:11357-11368. http://dx.doi.org/10.1074/jbc.M110.102459.
22. Xu X, Severson W, Villegas N, Schmaljohn CS, Jonsson CB. 2002. The RNA binding domain of the Hantaan virus N protein maps to a central, conserved region. J Virol 76:3301-3308. http://dx.doi.org/10.1128/JVI.76.7.3301-3308.2002.
23. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
24. Wang X, Spandidos A, Wang H, Seed B. 2012. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res 40:D1144-D1149. http://dx.doi.org/10.1093/nar/gkr1013.
25. Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H. 2010. Antagonism of type I interferon responses by New World hantaviruses. J Virol 84:11790-11801. http://dx.doi.org/10.1128/JVI.00916-10.
26. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE. 2007. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81:2769-2776. http://dx.doi.org/10.1128/JVI.02402-06.
27. Breckpot K, Emeagi P, Dullaers M, Michiels A, Heirman C, Thielemans K. 2007. Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum Gene Ther 18:536-546. http://dx.doi.org/10.1089/hum.2007.006.
28. Tan PH, Beutelspacher SC, Xue SA, Wang YH, Mitchell P, McAlister JC, Larkin DF, McClure MO, Stauss HJ, Ritter MA, Lombardi G, George AJ. 2005. Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105:3824-3832. http://dx.doi.org/10.1182/blood-2004-10-3880.
29. Tan PH, Xue SA, Manunta M, Beutelspacher SC, Fazekasova H, Alam AK, McClure MO, George AJ. 2006. Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol 26:462-467. http://dx.doi.org/10.1161/01.ATV.0000200083.95349.9e.
30. Brown BD, Sitia G, Annoni A, Hauben E, Sergi LS, Zingale A, Roncarolo MG, Guidotti LG, Naldini L. 2007. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109:2797-2805. http://dx.doi.org/10.1182/blood-2006-10-049312.
31. Li K, Chen Z, Kato N, Gale M, Jr, Lemon SM. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280:16739-16747. http://dx.doi.org/10.1074/jbc.M414139200.
32. Handke W, Oelschlegel R, Franke R, Kruger DH, Rang A. 2009. Hantaan virus triggers TLR3-dependent innate immune responses. J Immunol 182:2849-2858. http://dx.doi.org/10.4049/jimmunol.0802893.
33. Wek RC, Jiang HY, Anthony TG. 2006. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34:7-11. http://dx.doi.org/10.1042/BST0340007.
34. He B. 2006. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 13:393-403. http://dx.doi.org/10.1038/sj.cdd.4401833.
35. Ignowski JM, Schaffer DV. 2004. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng 86:827-834. http://dx.doi.org/10.1002/bit.20059.
36. He B, Gross M, Roizman B. 1997. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNAactivated protein kinase. Proc Natl Acad Sci U S A 94:843-848. http://dx.doi.org/10.1073/pnas.94.3.843.
37. Li Y, Zhang C, Chen X, Yu J, Wang Y, Yang Y, Du M, Jin H, Ma Y, He B, Cao Y. 2011. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. J Biol Chem 286:24785-24792. http://dx.doi.org/10.1074/jbc.M111.232439.
38. Tan SL, Tareen SU, Melville MW, Blakely CM, Katze MG. 2002. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. J Biol Chem 277:36109-36117. http://dx.doi.org/10.1074/jbc.M205109200.
39. Sadler AJ, Williams BR. 2007. Structure and function of the protein kinase R. Curr Top Microbiol Immunol 316:253-292. http://dx.doi.org/10.1007/978-3-540-71329-6_13.
40. Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J 17:5458-5465. http://dx.doi.org/10.1093/emboj/17.18.5458.
41. Nanduri S, Rahman F, Williams BR, Qin J. 2000. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J 19:5567-5574. http://dx.doi.org/10.1093/emboj/19.20.5567.
42. Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC. 2006. Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci U S A 103:10005-10010. http://dx.doi.org/10.1073/pnas.0602317103.
43. Dey M, Cao C, Dar AC, Tamura T, Ozato K, Sicheri F, Dever TE. 2005. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122:901-913. http://dx.doi.org/10.1016/j.cell.2005.06.041.
44. Dey M, Mann BR, Anshu A, Mannan MA. 2014. Activation of protein kinase PKR requires dimerization-induced cis-phosphorylation within the activation loop. J Biol Chem 289:5747-5757. http://dx.doi.org/10.1074/jbc.M113.527796.
45. Lemaire PA, Anderson E, Lary J, Cole JL. 2008. Mechanism of PKR activation by dsRNA. J Mol Biol 381:351-360. http://dx.doi.org/10.1016/j.jmb.2008.05.056.
46. Gale M, Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208-5218.
47. Gale MJ, Jr, Korth MJ, Katze MG. 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 10:157-162. http://dx.doi.org/10.1016/S0928-0197(98)00034-8.
48. Matthys VS, Cimica V, Dalrymple NA, Glennon NB, Bianco C, Mackow ER. 2014. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation. J Virol 88:2246-2259. http://dx.doi.org/10.1128/JVI.02647-13.
49. Matthys V, Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. 2011. The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction. J Virol 85:4752-4760. http://dx.doi.org/10.1128/JVI.01945-10.
50. Vapalahti O, Lundkvist A, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 77:3063-3067. http://dx.doi.org/10.1099/0022-1317-77-12-3063.
51. Johnson KM. 2001. Hantaviruses: history and overview. Curr Top Microbiol Immunol 256:1-14. http://dx.doi.org/10.1007/978-3-642-56753-7_1.
52. Plyusnin A, Vapalahti O, Lankinen H, Lehvaslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist A, Brummer-Korvenkontio M, Gavrilovskaya I, Vaheri A. 1994. Tula virus: a newly detected hantavirus carried by European common voles. J Virol 68:7833-7839.
53. McNulty S, Flint M, Nichol ST, Spiropoulou CF. 2013. Host mTORC1 signaling regulates Andes virus replication. J Virol 87:912-922. http://dx.doi.org/10.1128/JVI.02415-12.
54. Tan SL, Gale MJ, Jr, Katze MG. 1998. Double-stranded RNAindependent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor. Mol Cell Biol 18:2431-2443.
55. Melville MW, Tan SL, Wambach M, Song J, Morimoto RI, Katze MG. 1999. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity. J Biol Chem 274:3797-3803. http://dx.doi.org/10.1074/jbc.274.6.3797.
56. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. 2009. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5:e1000287. http://dx.doi.org/10.1371/journal.ppat.1000287.
57. Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. 2009. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNAdependent protein kinase. J Virol 83:4365-4375. http://dx.doi.org/10.1128/JVI.02148-08.
58. Cheng E, Wang Z, Mir MA. 2014. Interaction between hantavirus nucleocapsid protein (N) and RNA-dependent RNA polymerase (RdRp) mutants reveals the requirement of an N-RdRp interaction for viral RNA synthesis. J Virol 88:8706-8712. http://dx.doi.org/10.1128/JVI.00405-14.
59. Haque A, Mir MA. 2010. Interaction of hantavirus nucleocapsid protein with ribosomal protein S19. J Virol 84:12450-12453. http://dx.doi.org/10.1128/JVI.01388-10.
60. Sekellick MJ, Carra SA, Bowman A, Hopkins DA, Marcus PI. 2000. Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes. J Interferon Cytokine Res 20:963-970. http://dx.doi.org/10.1089/10799900050198408.
61. Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams BR. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 16:406-416. http://dx.doi.org/10.1093/emboj/16.2.406.
62. Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR. 2000. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol 20:1278-1290. http://dx.doi.org/10.1128/MCB.20.4.1278-1290.2000.
63. Lawrence T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651. http://dx.doi.org/10.1101/cshperspect.a001651.
64. Gil J, Esteban M. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114. http://dx.doi.org/10.1023/A:1009664109241.
65. Benedict CA, Norris PS, Ware CF. 2002. To kill or be killed: viral evasion of apoptosis. Nat Immunol 3:1013-1018. http://dx.doi.org/10.1038/ni1102-1013.
66. Gupta S, Braun M, Tischler ND, Stoltz M, Sundstrom KB, Bjorkstrom NK, Ljunggren HG, Klingstrom J. 2013. Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog 9:e1003272. http://dx.doi.org/10.1371/journal.ppat.1003272.
67. Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T. 2012. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7:e43031. http://dx.doi.org/10.1371/journal.pone.0043031.
68. Sumpter R, Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79:2689-2699. http://dx.doi.org/10.1128/JVI.79.5.2689-2699.2005.